Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

Recruiting

Phase 2

GS-1427Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor:

Gilead Sciences

Code:

NCT06290934

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

GS-1427

Placebo-to-match GS-1427

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-15. This information was provided to ClinicalTrials.gov by Gilead Sciences on 2025-10-22.